Northern Financial Advisors Inc

Position in LLY — ELI LILLY & Co

CIK 1962457 BLOOMFIELD HILLS, MI

Position in LLY

as of Jun 30, 2026 · filed Jul 28, 2026 Compact

Position Value

$2,290,911

+$523,114 QoQ

Shares Held

1,910

-0.6% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

1.55%

of 13F equity value

Holder Rank

#2,371

of 4,605 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Northern Financial Advisors Inc holds $8,250,442 across 7 Drug Manufacturers - General names. LLY ranks #1 (27.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co This page	1,910	$2,290,911
2	AMGN	Amgen Inc	3,847	$1,393,075
3	JNJ	Johnson & Johnson	4,699	$1,193,405
4	GILD	Gilead Sciences, Inc.	8,647	$1,092,461
5	MRK	Merck & Co., Inc.	8,398	$1,079,143
6	ABBV	AbbVie Inc.	3,712	$934,087
7	PFE	Pfizer Inc	11,103	$267,360

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,290,911	1,910	-0.6%	Shares	Sole	2026-07-28
2026-03-31	$1,767,797	1,922	+57.9%	Shares	Sole	2026-04-28
2025-12-31	$1,307,885	1,217	-39.4%	Shares	Sole	2026-01-27
2025-09-30	$1,532,104	2,008	-10.0%	Shares	Sole	2025-11-10
2025-06-30	$1,739,910	2,232	+11.2%	Shares	Sole	2025-07-23
2025-03-31	$1,657,601	2,007	-0.4%	Shares	Sole	2025-05-06
2024-12-31	$1,556,352	2,016	-19.2%	Shares	Sole	2025-01-30
2024-09-30	$2,210,420	2,495	-9.9%	Shares	Sole	2024-10-29
2024-06-30	$2,506,997	2,769	+11.8%	Shares	Sole	2024-08-05
2024-03-31	$1,927,006	2,477	-0.2%	Shares	Sole	2024-04-30
2023-12-31	$1,447,390	2,483	+66.1%	Shares	Sole	2024-02-06
2023-09-30	$803,009	1,495	-5.7%	Shares	Sole	2023-11-14
2023-06-30	$743,802	1,586	+0.6%	Shares	Sole	2023-07-21
2023-03-31	$541,573	1,577	+108.3%	Shares	Sole	2023-04-27
2022-12-31	$276,940	757	—	Shares	Sole	2023-01-30
No filing history on record for this holder in this stock.